Iopamidol Injection, Solution
Product Images NDC 70436-127

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Iopamidol (NDC 70436-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01.jpg (Image 01)

Chemical structure of iopamidol, showing its iodine atoms attached to a benzene ring with multiple hydroxyl and amide groups linked to the ring.*

FDA Label Image

Iimage-02.jpg (Image 02)

Label for iopamidol Injection, USP 20% (408 mg/mL) solution for intravascular use only, in a 50 mL single-dose vial. The label includes warnings against intrathecal use, storage instructions at 20° to 25°C, and information on the manufacturer and distributor: Slate Run Pharmaceuticals, LLC. The label also highlights a 41% concentration of organically bound iodine.*

FDA Label Image

Image-03.jpg (Image 03)

Label for iopamidol injection USP 510 mg/mL in a 50 mL single-dose vial by Slate Run Pharmaceuticals, LLC. The label indicates 25% organically bound iodine and highlights 'For Intravascular Use Only' in red text. Storage instructions specify 20° to 25°C with permitted excursions, and a note restricts use intrathecally. The label includes manufacturing and distribution details, lot and expiration date areas, and a barcode.*

FDA Label Image

Image-04.jpg (Image 04)

Label for iopamidol injection, USP, 30 mL single-dose vial with 30% organically bound iodine. Contains usage instruction emphasizing 'For Intravascular Use Only' in red text. Includes storage instructions at 20° to 25°C with permitted excursions, manufacturer and distributor information, and NDC 70436-219-36. Labeler is Slate Run Pharmaceuticals, LLC.*

FDA Label Image

Image-05.jpg (Image 05)

iopamidol Injection, 612 mg/mL, solution for injection in a 50 mL single-dose vial by Slate Run Pharmaceuticals, LLC. Label states 30% organicially bound iodine, designated for intravascular use only, with storage instructions and manufacturer details. The lot and expiration coating area is visible but does not have printed data.*

FDA Label Image

Image-06.jpg (Image 06)

Label for iopamidol injection, USP, 612 mg/mL, intravascular use only, in a 100 mL single-dose vial. The label indicates the drug contains 30% organically bound iodine, with storage instructions and manufacturer details for Slate Run Pharmaceuticals, LLC.*

FDA Label Image

Image-07.jpg (Image 07)

Label for iopamidol injection, USP, 755 mg/mL, intravascular use only, supplied in a 50 mL single-dose vial. The label specifies 37% organically bound iodine and indicates it is made by Slate Run Pharmaceuticals, LLC. The label includes storage instructions, warnings, and lot/expiration date fields, with a barcode on the right side.*

FDA Label Image

Image-08.jpg (Image 08)

iopamidol Injection, USP 76% solution for intravascular use only, containing 75 mL in a single-dose vial. Contains 3% organically bound iodine. Labeler is Slate Run Pharmaceuticals, LLC. Storage instructions specify 20° to 25°C with excursions permitted to 15° to 30°C. The label includes warnings against intrathecal use and discard instructions for unused portions.*

FDA Label Image

Image-09.jpg (Image 09)

Label for iopamidol Injection, USP 755 mg/mL, an intravascular injection solution. The single-dose vial contains 100 mL and is marked for 37% organically bound iodine and 76% concentration. The label includes warnings for intrathecal use and storage instructions, with manufacturer and distributor information provided by Slate Run Pharmaceuticals, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.